Search Results 191-200 of 19293 for prostate cancer
... gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area in patients with prostate cancer to find out which is better ...
Previous or concurrent malignancy other than non-melanoma skin cancer within 5 years of diagnosis of prostate cancer; Inability to start the protocol ...
... prostate cancer recurrence after RT. Serum CgA level is measured before the start of RT and/or the start of neoadjuvant ADT for patients undergoing a ...
Prior androgen suppression therapy for prostate cancer for more than 6 months; Active rectal diverticulitis, Crohn?s disease affecting the rectum or ulcerative ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic ...
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
Prior whole gland ablative therapy (i.e. cryoablation or high intensity focused ultrasound [HIFU]) for prostate cancer is not allowed. HIV positive with CD4 ...
Clinicians inform men ages 55 to 69 years about the potential benefits and harms of prostate-specific antigen (PSA)–based screening for prostate cancer. Many ...
Prostate cancer and prostatic diseases. 2020. Mar; 23(1):38-52. Theranostic principles utilize a molecular biomarker specific for a tumor target, initially ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.